This is a routine plan-related PDMR transaction with no trading signal. No action warranted. Monitor next quarterly filing for operational updates.
GSK drugs
GSK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $48.12entry
- T+1 · 2mo ago +0.02%α −0.83% · $48.13
- T+5 · 2mo ago +6.11%α +6.61% · $51.06
- T+20 · 6w ago −3.28%α −5.41% · $46.54
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
This is a routine 6-K filing disclosing a PDMR transaction: Maya Martinez-Davis, President US, acquired 9.837 notional ADS at $48.54 within her GSK Executive Supplemental Savings Plan account. The transaction is a plan-related notional acquisition, not an open-market purchase, and is immaterial in size (~$477 total). No material financial or operational information is disclosed.
Key Facts
- Maya Martinez-Davis, President US, acquired 9.837 notional ADS at $48.54 on 2026-09-08 within her GSK Executive Supplemental Savings Plan account.
- Total value of the transaction is approximately $477, which is immaterial relative to GSK's $98.4B market cap.
- This is a plan-related notional acquisition, not a discretionary open-market purchase, and carries no signaling value.
Financial Impact
No material financial impact, transaction value ~$477, immaterial for a $98.4B market cap company.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-008255 |
| Document: 0001654954-26-008255-index-headers.html | 0001654954-26-008255 |
| Document: 0001654954-26-008255-index.html | 0001654954-26-008255 |
| Document: 0001654954-26-008255.txt | 0001654954-26-008255 |
Track record
64 reports on GSK
9 of 18 bullish or bearish reports moved the stock their way by T+20. Best: +9.35% at T+60 after the Jul 17, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 13, 20263d ago 6-K Neutral 4/10 Entry $50.45 Now $50.41 −0.08% settles Dec 14
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $50.64 Now $50.41 −0.45% settles Dec 11
- Nov 6, 202610d ago 6-K Neutral 1/10 Entry $50.33 Now $50.41 +0.16% settles Dec 7
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $49.13 Now $50.41 +2.61% settles Dec 1
- Oct 28, 202619d ago 6-K Neutral 5/10 Entry $48.74 Now $50.41 +3.43% settles Nov 25
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 1/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 26, 202621d ago 6-K Neutral 4/10 Entry $51.10 Now $50.41 −1.35% settles Nov 23
- Oct 21, 202626d ago 6-K Bullish 7/10 Entry $50.02 Now $50.41 +0.78% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers